M L Slevin

A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicity.

R. Reznek, W. Gregory, M. Slevin, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.

W. Gregory, M. Slevin, H. Plant, 1990, BMJ.

Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphy.

K E Britton, M Granowska, M. Slevin, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.

D G Lowe, R. Reznek, W. Gregory, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluating and designing cancer chemotherapy treatment using mathematical models.

M L Slevin, W M Gregory, B G Birkhead, 1986, European journal of cancer & clinical oncology.

Cancer information: a cost-effective intervention.

M Boudioni, M. Slevin, J. Mossman, 1999, European journal of cancer.

BACUP--the first two years: evaluation of a national cancer information service.

M. Slevin, T. Mcelwain, S. Jefferies, 1988, BMJ.

Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment

T. Lister, M. Slevin, P. Wilson, 1994, BMJ.

Respiratory depression following morphine and morphine-6-glucuronide in normal subjects.

M. Slevin, S. Joel, M L Slevin, 1995, British journal of clinical pharmacology.